Glioblast Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Glioblast General Information
Description
Owner and operator of an oncology focused biotechnology company located in Sydney, Australia. The company offers clinical research and development services for improving diagnosis and treatment of brain tumor and cancer.
Contact Information
Corporate Office
- Sydney, New South Wales
- Australia
Corporate Office
- Sydney, New South Wales
- Australia
Glioblast Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Glioblast Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Glioblast FAQs
-
Where is Glioblast headquartered?
Glioblast is headquartered in Sydney, Australia.
-
What industry is Glioblast in?
Glioblast’s primary industry is Biotechnology.
-
Is Glioblast a private or public company?
Glioblast is a Private company.
-
What is the current valuation of Glioblast?
The current valuation of Glioblast is .
-
What is Glioblast’s current revenue?
The current revenue for Glioblast is .
-
Who are Glioblast’s investors?
Genentech has invested in Glioblast.
-
When was Glioblast acquired?
Glioblast was acquired on 31-Oct-2016.
-
Who acquired Glioblast?
Glioblast was acquired by Kazia Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process